Latest Breaking News On - D mark mcclung - Page 1 : comparemela.com

StockWatch: Sangamo Downgraded after Layoffs, Restructuring

StockWatch: Sangamo Downgraded after Layoffs, Restructuring
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleAlex philippidisJim birchenoughD mark mcclungGregory davisNicole germinoSandy macraeAndreas argyridesKamy poolerBarclay gena wangMaury raycroftJason fontenotWells fargoSangamo research centerMaravai lifesciences holdingsGilead company

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Longtime BioMarin CEO hands off baton—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ocuphire pharmaAmit mehtaDerrell porterKirsty sempleErin lavelleCellevolve bioSarah coleTodd dickinsonAdrian rayPaul frohnaMichelle shuffettJennifer towneMarguerite hutchinsonChristian howellLori kunkelDaiichi sankyo plexxikon

Rani and Sangamo jettison staff, assets to keep afloat next year

Rani and Sangamo jettison staff, assets to keep afloat next year
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesTalat imranD mark mcclungJohnson crohnSandy macraeJason fontenotRani therapeuticsSangamo therapeuticsChief operating officerChief scientific officer jason fontenot

Sangamo to cut jobs again with planned business overhaul

BioPharma

United statesD mark mcclungJason fontenotKamy poolerGregory davisSandy macraeDive briefChief operating officerChief scientific

Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results

01.11.2023 - Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including progress on its strategic transformation and a corresponding restructuring of operations and workforce reduction, and .

United statesLang schwarzGregory davisD mark mcclungJason fontenotKamy poolerSafety monitoring committeeAmerican society for hematology annual meetingExchange commissionHead of researchHead of technologyEuropean society of geneExecutive vice presidentChief operating officerSenior vice presidentChief scientific officer